Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04460417 · ClinicalTrials.gov registry record · NA

Chicago Community Health Study

A NA study, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
204
Enrollment target

NCT04460417: Completed NA study, sponsored by University of Chicago.

NCT04460417 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 204 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04460417, a NA study, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
204 participants
Enrollment target

Study Summary

The study examined smokers from the initial COMPASS survey who live in one of three local Census tracks with large concentrations of minority populations and smoking rates, including Washington Park (98.8% African American, 60.5% smoker), Gage Park (76.7% Hispanic, 26.7% smoker), and Bridgeport (34.5% Asian, 27.0% Hispanic, 29.3% smoker), randomizing them to receipt of treatment as usual care advice (via a pamphlet form the National Cancer Institute) versus theoretically-driven and empirically-supported smoking cessation advice session delivered in-person at the UCM.

Primary Outcome

Change in average cigarettes per day (CPD)

Interventions

  • BEHAVIORAL TAU
  • BEHAVIORAL Enhanced Care

Trial Details

FieldValue
Enrollment Target 204 participants
Start Date 2017-10-01
Est. Completion 2018-10-31
Phase NA
University of Chicago

796 total trials

What the finished NCT04460417 record still lists

NCT04460417 is an interventional study that assigns participants to a tested intervention. The registered 204 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 2 interventions - of which TAU is the first listed.

NCT04460417 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04460417 about?

NCT04460417 is a clinical study titled "Chicago Community Health Study". The study examined smokers from the initial COMPASS survey who live in one of three local Census tracks with large concentrations of minority populations and smoking rates, including Washington Park (98.8% African American, 60.5% smoker), Gage Park (76.7% Hispanic, 26.7% smoker), and Bridgeport (34....

What is the current status of trial NCT04460417?

This trial is currently completed. It is a NA study. The enrollment target is 204 participants. The study started on 2017-10-01. Estimated completion is 2018-10-31.

What interventions are being tested in trial NCT04460417?

The interventions under investigation include: TAU (BEHAVIORAL), Enhanced Care (BEHAVIORAL).

Who is sponsoring clinical trial NCT04460417?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04460417's enrollment target sits among peer trials

204 500th of 2000 higher than 1,497 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03481010 · 204 participants · NA

    Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology

  • NCT04249830 · 204 participants · NA

    Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults

  • NCT04503395 · 204 participants · NA

    ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

  • NCT04793776 · 204 participants · NA

    Manage Emotions to Reduce Aggression (MERA)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04460417, the US trial registry maintained by the National Library of Medicine. NCT04460417 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.